Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,739
Total Claims
$558K
Drug Cost
521
Beneficiaries
$1,071
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+207%
Opioid rate vs peers
11.6% vs 3.8% avg
-9%
Cost per patient vs peers
$1,071 vs $1,174 avg
+62%
Brand preference vs peers
14.3% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 207% above Nurse Practitioner peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
11.6%
Opioid Rate
1,014
Opioid Claims
$17K
Opioid Cost
4.2%
Long-Acting Rate
Brand vs Generic
Brand: 1,242 claims · $356K
Generic: 7,428 claims · $197K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 278 | $96K |
| Rivaroxaban | 72 | $22K |
| Potassium Chloride | 349 | $16K |
| Hydrocodone/Acetaminophen | 729 | $14K |
| Eluxadoline | 22 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 60 | $9,249 |
| Pantoprazole Sodium | 198 | $8,643 |
| Pregabalin | 144 | $8,531 |
| Linaclotide | 15 | $8,204 |
| Umeclidinium Bromide | 16 | $8,136 |
| Gabapentin | 526 | $7,664 |
| Mirabegron | 32 | $7,190 |
| Insulin Aspart | 43 | $7,100 |
| Naloxegol Oxalate | 33 | $6,462 |
| Insulin Glargine,hum.Rec.Anlog | 19 | $5,969 |
Prescribing Profile
Patient Profile
78
Avg Age
63%
Female
2.81
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About